Ann: Immuron Aims to Secure FDA Approval for IMM-124E, page-22

Immuron is going to get FDA approval within 60 days. Aside from the massive increase in sales from being prescribed by doctors, it means US DoD can confidently order for troops. Huge sales.
Also NIH sponsored ASH results within 80 days. Should nail the LPS primary endpoint as great LPS results in previous trials. These two catalysts should propel to above 60/70 cents. Cap would still be less than USD$100mio up there, so not overvalued. Also likely that will partner Fatty liver (NASH, ASH, NAFLD) after ASH results & get a decent upfront & headlines from partnership. Then Immuron will focus on amazing potential of Cdiff & the opportunities of the platform (Shigella by DoD, Autism etc). I'd say base is in, algos on Nasdaq only sold 1200 at 4.85. Should have been trading 5.60 as per ASX. Anyway soon be $20* or 70cents+. Amazing money to be made from here on. The most money is made by sitting on your hands.